Troglitazone increases system A amino acid transport in 3T3-L1 cells

Endocrinology

Volumn 139, Issue 3, 1998, Pages 832-837

  Su, Ti Zhi ^a   Wang, Minghan ^a   Oxender, Dale L ^a   Saltiel, Alan R ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CYCLOHEXIMIDE; DACTINOMYCIN; INSULIN; MESSENGER RNA; TROGLITAZONE;

ADIPOCYTE; AMINO ACID METABOLISM; AMINO ACID TRANSPORT; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL STRAIN 3T3; ENZYME SPECIFICITY; GENE EXPRESSION; HORMONE ACTION; INSULIN SENSITIVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM;

EID: 0031794486     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.139.3.5795     Document Type: Article

References (32)

1. McGivan JD, Pastor Anglada M 1994 Regulatory and molecular aspects of mammalian amino acid transport. Biochem J 299:321-334
2. Collarini EJ, Oxender DL 1987 Mechanisms of transport of amino acids across membranes. Annu Rev Nutr 7:75-90
3. Saltiel AR, Olefsky JM 1996 Thiazolidinediones in the treatment of insulin resistance and type II diabetes. Diabetes 45:1661-1669
4. Lehmann JM, Moore LB, Smith Oliver TA, Wilkison WO, Willson TM, Kliewer SA 1995 An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma. J Biol Chem 270:12953-12956
5. Pearson SL, Cawthorne MA, Clapham JC, Dunmore SJ, Holmes SD, Moore GB, Smith SA, Tadayyon M 1996 The thiazolidinedione insulin sensitiser, BRL 49653, increases the expression of PPAR-gamma and aP2 in adipose tissue of high-fat-fed rats. Biochem Biophys Res Commun 229:752-757
6. Tai TAC, Jennermann C, Brown KK, Oliver BB, MacGinnitie MA, Wilkison WO, Brown HR, Lehmann JM, Kliewer SA, Morris DC, Graves RA 1996 Activation of the nuclear receptor peroxisome proliferator-activated receptor gamma promotes brown adipocyte differentiation. J Biol Chem 271:29909-29914
7. Gimble JM, Robinson CE, Wu X, Kelly KA, Rodriguez BR, Kliewer SA, Lehmann JM, Morris DC 1996 Peroxisome proliferator-activated receptor-gamma activation by thiazolidinediones induces adipogenesis in bone marrow stromal cells. Mol Pharmacol 50:1087-94
8. Lambe KG, Tugwood JD 1996 A human peroxisome-proliferator-activated receptor-gamma is activated by inducers of adipogenesis, including thiazolidinedione drugs. Eur J Biochem 239:1-7
9. Tontonoz P, Singer S, Forman BM, Sarraf P, Fletcher JA, Fletcher CD, Brun RP, Mueller E, Altiok S, Oppenheim H, Evans RM, Spiegelman BM 1997 Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor gamma and the retinoid X receptor. Proc Natl Acad Sci USA 94:237-241
10. Hollenberg AN, Susulic VS, Madura JP, Zhang B, Moller DE, Tontonoz P, Sarraf P, Spiegelman BM, Lowell BB 1997 Functional antagonism between CCAAT/enhancer binding protein-alpha and peroxisome proliferator-activated receptor-gamma on the leptin promoter. J Biol Chem 272:5283-5290
11. De-Vos P, Lefebvre AM, Miller SG, Guerre Millo M, Wong K, Saladin R, Hamann LG, Staels B, Briggs MR, Auwerx J 1996 Thiazolidinediones repress ob gene expression in rodents via activation of peroxisome proliferator-activated receptor gamma. J Clin Invest 98:1004-1009
12. Kallen CB, Lazar MA 1996 Antidiabetic thiazolidinediones inhibit leptin (ob) gene expression in 3T3-L1 adipocytes. Proc Natl Acad Sci USA 93:5793-5796
13. Schoonjans K, Peinado Onsurbe J, Lefebvre AM, Heyman RA, Briggs M, Deeb S, Staels B, Auwerx J 1996 PPARalpha and PPARgamma activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene. EMBO J 15:5336-5348
14. Willson TM, Cobb JE, Cowan DJ, Wiethe RW, Correa ID, Prakash SR, Beck KD, Moore LB, Kliewer SA, Lehmann JM 1996 The structure-activity relationship between peroxisome proliferator-activated receptor gamma agonism and the antihyperglycemic activity of thiazolidinediones. J Med Chem 39:665-668
15. Berger J, Bailey P, Biswas C, Cullinan CA, Doebber TW, Hayes NS, Saperstein R, Smith RG, Leibowitz MD 1996 Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-γ: binding and activation correlate with antidiabetic actions in db/db mice. Endocrinology 137:4189-4195
16. Tafuri SR 1996 Troglitazone enhances differentiation, basal glucose uptake, and Glut1 protein levels in 3T3-L1 adipocytes. Endocrinology 137:4706-4712
17. Sandouk T, Reda D, Hofmann C 1993 The antidiabetic agent pioglitazone increases expression of glucose transporters in 3T3-F442A cells by increasing messenger ribonucleic acid transcript stability. Endocrinology 133:352-359
18. Ohsumi J, Sakakibara S, Yamaguchi J, Miyadai K, Yoshioka S, Fujiwara T, Horikoshi H, Serizawa N 1994 Troglitazone prevents the inhibitory effects of inflammatory cytokines on insulin-induced adipocyte differentiation in 3T3-L1 cells. Endocrinology 135:2279-2282
19. el-Kebbi IM, Roser S, Pollet RJ 1994 Regulation of glucose transport by pioglitazone in cultured muscle cells. Metabolism 43:953-958
20. Ciaraldi TP, Huber-Knudsen K, Hickman M, Olefsky JM 1995 Regulation of glucose transport in cultured muscle cells by novel hypoglycemic agents. Metabolism 44:976-981
21. Bahr M, Spelleken M, Bock M, von-Holtey M, Kiehn R, Eckel J 1996 Acute and chronic effects of troglitazone (CS-045) on isolated rat ventricular cardiomyocytes. Diabetologia 39:766-774
22. Young PW, Cawthorne MA, Coyle PJ, Holder JC, Holman GD, Kozka IJ, Kirkham DM, Lister CA, Smith SA 1995 Repeat treatment of obese mice with BRL 49653, a new potent insulin sensitizer, enhances insulin action in white adipocytes. Association with increased insulin binding and cell-surface GLUT4 as measured by photoaffinity labeling. Diabetes 44:1087-1092
23. Felig P, Marliss E, Ohman JL, Cahill Jr CF 1970 Plasma amino acid levels in diabetic ketoacidosis. Diabetes 19:727-728
24. Vannini P, Marchesini G, Forlani G, Angiolini A, Ciavarella A, Zoli M, Pisi E 1982 Branched-chain amino acids and alanine as indices of the metabolic control in type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetic patients. Diabetologia 22:217-219
25. Brosnan JT, Man KC, Hall DE, Colbourne SA, Brosnan ME 1983 Interorgan metabolism of amino acids in streptozotocin-diabetic ketoacidotic rat. Am J Physiol 244:E151-E158
26. Sjoberg RJ, Kidd GS 1989 Pancreatic diabetes mellitus. Diabetes Care 12:715-724
27. Nakamura T, Takebe K, Kudoh K, Ishii M, Imamura K, Kikuchi H, Kasai F, Tandoh Y, Yamada N, Arai Y, Terada A, Machida K 1994 Increased plasma gluconeogenic and system A amino acids in patients with pancreatic diabetes due to chronic pancreatitis in comparison with primary diabetes. Tohoku J Exp Med 173:413-420
28. Stumvoll M, Perriello G, Nurjhan N, Bucci A, Welle S, Jansson PA, Dailey G, Bier D, Jenssen T, Gerich J 1996 Glutamine and alanine metabolism in NIDDM. Diabetes 45:863-868
29. Su TZ, Campbell GW, Oxender DL 1997 Glutamine transport in cerebellar granule cells in culture. Brain Res 757:69-78
30. Su TZ, Wang M, Saltiel AR, Oxender DL, Regulation of system A amino acid transport in 3T3-L1 adipocytes by insulin. J Biol Chem, in press
31. Shotwell MA, Kilberg MS, Oxender DL 1983 The regulation of neutral amino acid transport in mammalian cells. Biochim Biophys Acta 737:267-284
32. Maegawa H, Ide R, Hasegawa M, Ugi S, Egawa K, Iwanishi M, Kikkawa R, Shigeta Y, Kashiwagi A 1995 Thiazolidine derivatives ameliorate high glucose-induced insulin resistance via the normalization of protein-tyrosine phosphatase activities. J Biol Chem 270:7724-7730